JNP

Juniper Pharmaceuticals, Inc. Common Stock
JNP

Delisted

JNP was delisted on the 13th of August, 2018.

31 hedge funds and large institutions have $18.2M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
9
Reduced
9
Closed
6
Calls
Puts
$51K
Net Calls
-$51K
Net Calls Change
-$51K
Name Holding Trade Value Shares
Change
Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$31K +$117 +26 +0.4%
TRCT
27
Tower Research Capital (TRC)
New York
$14K +$11.4K +2,414 +431%
Simplex Trading
28
Simplex Trading
Illinois
$6K +$6K +1,437 New
UBS Group
29
UBS Group
Switzerland
$1K -$16.5K -2,058 -94%
FWM
30
Focused Wealth Management
New York
$1K
AIC
31
AWM Investment Company
New York
-$505K -100,000 Closed
Goldman Sachs
32
Goldman Sachs
New York
-$110K -21,735 Closed
TC
33
TFS Capital
Pennsylvania
-$83K -16,490 Closed
AIM
34
Acrospire Investment Management
Illinois
-$43K -8,423 Closed
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$2K -386 Closed